We are very pleased to announce that Alcidion has entered into binding agreements to acquire health informatics software and services company MKM health in Australia and New Zealand, and Patientrack in the UK.
This transformative Acquisition creates a new and leading specialist health IT solution provider focused on “next generation” decision intelligence technology designed for hospital and allied healthcare customers globally. Patientrack and Alcidion’s existing Miya and Smartpage product sets will provide the expanded group with a strong foundation of complementary technologies.
The Acquisition expands Alcidion’s international and domestic footprint substantially with a diversified customer base including 20 National Health Service (NHS) hospitals in the UK including the largest NHS Trust, more than 50 Australian public and private hospitals and Health Departments as well as 11 District Health Boards covering more than 30 New Zealand hospitals.
MKM Chief Executive Officer Kate Quirke has been appointed as CEO of Alcidion Group and Ray Blight Executive Chairman. MKM Health’s products are highly complementary with Alcidion’s software suite, and the acquisition creates valuable synergistic and upscaling opportunities for both companies.
For now, it is business as usual, and no changes for our valued customers. The transaction is subject to an Alcidion shareholder vote at an Extraordinary General Meeting expected to take place in early June. Completion of the acquisition is expected on 29th June. Read the full release